• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗马尼亚西北部二十年儿童炎症性肠病:表型特征与诊断趋势

Two Decades of Pediatric Inflammatory Bowel Disease in North-Western Romania: Phenotypic Characteristics and Diagnostic Trends.

作者信息

Tartamus Tita Georgia Valentina, Serban Daniela Elena, Tantau Marcel Vasile

机构信息

3rd Medical Discipline, Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Department of Mother and Child, 2nd Clinic of Pediatrics, Emergency Clinical Hospital for Children, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400177 Cluj-Napoca, Romania.

出版信息

J Clin Med. 2025 Jun 28;14(13):4597. doi: 10.3390/jcm14134597.

DOI:10.3390/jcm14134597
PMID:40648971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12250098/
Abstract

: Pediatric inflammatory bowel disease (pIBD), including Crohn's disease (CD), ulcerative colitis (UC), and IBD-unclassified (IBD-U), exhibits unique clinical features compared to adult-onset disease. This study aimed to describe phenotypic characteristics of pIBD in the north-west region of Romania over a 21-year period and to compare our findings with those of other studies worldwide. : We conducted a retrospective study of children under 18 years of age, from the north-west region of Romania, diagnosed with pIBD between 2000 and 2020 at the Emergency Clinical Hospital for Children, Cluj-Napoca. Disease phenotype at diagnosis was established according to the Paris classification. Data were collected from the hospital records and analyzed using descriptive statistics and univariate analysis of categorical variables. A -value < 0.05 was considered statistically significant. : Ninety-four patients were included (CD: 51.0%; UC: 43.6%; IBD-U: 5.4%), with a median age at diagnosis of 14 years (11-15.7). Very early-onset IBD accounted for 5.3% of cases. The likelihood of being diagnosed with CD after 10 years of age was significantly higher compared to UC (OR = 4.75, 95% CI: 1.10-29.07, = 0.03). UC most frequently presented as pancolitis (51.2%), while CD most often involved the ileocolonic region (56.3%). Inflammatory behavior was the most common CD phenotype (69%). Upper gastrointestinal involvement was documented in 18.7% of CD cases, with detection rates increasing after 2014. Perianal disease and growth impairment were significantly associated with complicated CD behavior ( = 0.03, and = 0.007 respectively). Our findings are broadly consistent with other published reports. : This study provides the first detailed phenotypic characterization of pIBD in this region. Our findings reflect trends observed in other populations and underscore the importance of standardized diagnostic evaluation.

摘要

小儿炎症性肠病(pIBD),包括克罗恩病(CD)、溃疡性结肠炎(UC)和未分类的IBD(IBD-U),与成人发病的疾病相比具有独特的临床特征。本研究旨在描述罗马尼亚西北地区21年间pIBD的表型特征,并将我们的研究结果与全球其他研究进行比较。

我们对罗马尼亚西北地区18岁以下、2000年至2020年期间在克卢日-纳波卡市儿童急诊临床医院被诊断为pIBD的儿童进行了一项回顾性研究。诊断时的疾病表型根据巴黎分类法确定。数据从医院记录中收集,并使用描述性统计和分类变量的单变量分析进行分析。P值<0.05被认为具有统计学意义。

纳入了94例患者(CD:51.0%;UC:43.6%;IBD-U:5.4%),诊断时的中位年龄为14岁(11-15.7岁)。极早发型IBD占病例的5.3%。10岁后被诊断为CD的可能性显著高于UC(OR=4.75,95%CI:1.10-29.07,P=0.03)。UC最常表现为全结肠炎(51.2%),而CD最常累及回结肠区域(56.3%)。炎症行为是最常见的CD表型(69%)。18.7%的CD病例有上消化道受累,2014年后检出率增加。肛周疾病和生长发育障碍与复杂的CD行为显著相关(分别为P=0.03和P=0.007)。我们的研究结果与其他已发表的报告大致一致。

本研究提供了该地区pIBD首个详细的表型特征描述。我们的研究结果反映了在其他人群中观察到的趋势,并强调了标准化诊断评估的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22a/12250098/c7dc9a37d6ec/jcm-14-04597-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22a/12250098/0d4d396a6e3a/jcm-14-04597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22a/12250098/c7dc9a37d6ec/jcm-14-04597-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22a/12250098/0d4d396a6e3a/jcm-14-04597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22a/12250098/c7dc9a37d6ec/jcm-14-04597-g002.jpg

相似文献

1
Two Decades of Pediatric Inflammatory Bowel Disease in North-Western Romania: Phenotypic Characteristics and Diagnostic Trends.罗马尼亚西北部二十年儿童炎症性肠病:表型特征与诊断趋势
J Clin Med. 2025 Jun 28;14(13):4597. doi: 10.3390/jcm14134597.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
4
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.维多珠单抗用于儿童炎症性肠病的维持治疗(VEDOKIDS):一项多中心、前瞻性队列研究的54周结果
Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6.
5
Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease.结肠和回肠克罗恩病的长期预后:一项基于人群的儿童期发病疾病二十年研究
Inflamm Bowel Dis. 2025 Jun 25. doi: 10.1093/ibd/izaf133.
6
Malignancy and Inflammatory Bowel Disease (IBD): Incidence and Prevalence of Malignancy in Correlation to IBD Therapy and Disease Activity-A Retrospective Cohort Analysis over 5 Years.恶性肿瘤与炎症性肠病(IBD):与IBD治疗及疾病活动相关的恶性肿瘤发病率和患病率——一项为期5年的回顾性队列分析
Biomedicines. 2025 Jun 6;13(6):1395. doi: 10.3390/biomedicines13061395.
7
Association of Serum Levels of Ustekinumab, Vedolizumab, and Faecal Calprotectin in Paediatric Patients with Inflammatory Bowel Diseases: A Prospective Observational Study.儿童炎症性肠病患者血清中乌司奴单抗、维多珠单抗水平与粪便钙卫蛋白的相关性:一项前瞻性观察研究。
Paediatr Drugs. 2025 Jun 26. doi: 10.1007/s40272-025-00702-9.
8
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
9
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
10
Oral budesonide for induction of remission in ulcerative colitis.口服布地奈德诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD007698. doi: 10.1002/14651858.CD007698.pub3.

本文引用的文献

1
Pediatric Inflammatory Bowel Disease in Romania: The First Epidemiological Study of the North-West Region (2000-2020).罗马尼亚的儿童炎症性肠病:西北地区的首次流行病学研究(2000 - 2020年)
Children (Basel). 2025 Mar 22;12(4):403. doi: 10.3390/children12040403.
2
Implementing routine medical and mental health screening in children and adolescents with inflammatory bowel disease.对炎症性肠病患儿及青少年实施常规医学和心理健康筛查。
J Pediatr Gastroenterol Nutr. 2025 Jul;81(1):43-52. doi: 10.1002/jpn3.70039. Epub 2025 Apr 23.
3
Disease phenotypic and outcome of very-early onset inflammatory bowel disease in Asian children: an understudied population.
亚洲儿童极早发型炎症性肠病的疾病表型与结局:一个研究不足的群体。
Front Pediatr. 2025 Feb 20;13:1487253. doi: 10.3389/fped.2025.1487253. eCollection 2025.
4
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.欧洲克罗恩病治疗指南:药物治疗
J Crohns Colitis. 2024 Oct 15;18(10):1531-1555. doi: 10.1093/ecco-jcc/jjae091.
5
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN.儿童溃疡性直肠炎患者的临床特征和自然病史:来自 ESPGHAN 的 Porto 儿童 IBD 小组的一项多中心研究。
J Crohns Colitis. 2023 Dec 30;17(12):1939-1948. doi: 10.1093/ecco-jcc/jjad111.
6
Approach to Endoscopic Balloon Dilatation in Pediatric Stricturing Crohn Disease: A Position Paper of the Endoscopy Special Interest Group of ESPGHAN.儿童狭窄型克罗恩病内镜球囊扩张治疗方法:欧洲儿科胃肠病学、肝病学和营养学会内镜学专业组立场文件
J Pediatr Gastroenterol Nutr. 2023 Jun 1;76(6):799-806. doi: 10.1097/MPG.0000000000003752. Epub 2023 Mar 2.
7
Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study.非常早发型炎症性肠病和婴儿起病型疾病的发病情况、治疗和结局:Epi-IIRN 研究。
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2639-2648.e6. doi: 10.1016/j.cgh.2022.10.026. Epub 2022 Nov 3.
8
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.克罗恩病患儿采用单纯肠内营养诱导缓解:更高依从性和反应率的决定因素。
Inflamm Bowel Dis. 2023 Sep 1;29(9):1380-1389. doi: 10.1093/ibd/izac215.
9
Epidemiological characteristics of Asian children with inflammatory bowel disease at diagnosis: Insights from an Asian-Pacific multi-centre registry network.亚洲炎症性肠病儿童确诊时的流行病学特征:来自亚太地区多中心注册网络的见解。
World J Gastroenterol. 2022 May 7;28(17):1830-1844. doi: 10.3748/wjg.v28.i17.1830.
10
Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry.意大利儿科炎症性肠病的流行病学趋势:意大利儿科胃肠病学、肝病学和营养学学会注册中心的 10 年分析。
Dig Liver Dis. 2022 Apr;54(4):469-476. doi: 10.1016/j.dld.2021.12.018. Epub 2022 Feb 4.